Education
About Us
Working with TipRanks
Follow Us
Precigen, Inc. (DE:I5X)
:I5X
I5X Analyst Ratings
Strong Buy
3 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
I5X Stock 12 Month Forecast
Average Price Target
€7.14
▲(125.18% Upside)
| Highest Price Target€7.35 | Average Price Target€7.14 | Lowest Price Target€6.92 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Cantor Fitzgerald
―
Buy
―
Reiterated
09/26/25
H.C. Wainwright
€7.37
Buy
132.62%
Upside
Reiterated
08/19/25
Buy Rating for Precigen: Strong Market Potential and Strategic Positioning of PapzimeosValuation and Risks. We maintain our price target of $8.50 per diluted share and our Buy rating on PGEN. We derive our price target based on a risk-adjusted net present value (rNPV) analysis of projected future revenues from Papzimeos (formerly PRGN-2012), assuming a 12.0% discount rate and a 0% terminal growth rate. We derive an rNPV of approximately $3.0B for Papzimeos and net cash and cash equivalents of $60M to arrive at a 12-month price target of $8.50.
Citizens JMP
€5.21→€6.94
Buy
118.94%
Upside
Reiterated
08/18/25
J.P. Morgan
―
Hold
―
Upgraded
08/15/25
Wells Fargo
€6.07
Buy
91.57%
Upside
Reiterated
03/20/25
Citi
€5.21
Buy
64.21%
Upside
Reiterated
03/19/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Cantor Fitzgerald
―
Buy
―
Reiterated
09/26/25
H.C. Wainwright
€7.37
Buy
132.62%
Upside
Reiterated
08/19/25
Buy Rating for Precigen: Strong Market Potential and Strategic Positioning of PapzimeosValuation and Risks. We maintain our price target of $8.50 per diluted share and our Buy rating on PGEN. We derive our price target based on a risk-adjusted net present value (rNPV) analysis of projected future revenues from Papzimeos (formerly PRGN-2012), assuming a 12.0% discount rate and a 0% terminal growth rate. We derive an rNPV of approximately $3.0B for Papzimeos and net cash and cash equivalents of $60M to arrive at a 12-month price target of $8.50.
Citizens JMP
€5.21→€6.94
Buy
118.94%
Upside
Reiterated
08/18/25
J.P. Morgan
―
Hold
―
Upgraded
08/15/25
Wells Fargo
€6.07
Buy
91.57%
Upside
Reiterated
03/20/25
Citi
€5.21
Buy
64.21%
Upside
Reiterated
03/19/25
Best Analysts Covering Precigen
1 Month
xxx
Success Rate
14/28 ratings generated profit
Average Return
+5.19%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +5.19% per trade.
3 Months
xxx
Success Rate
8/14 ratings generated profit
Average Return
+23.21%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +23.21% per trade.
1 Year
Success Rate
10/14 ratings generated profit
Average Return
+89.31%
reiterated a buy rating 3 months ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +89.31% per trade.
2 Years
xxx
Success Rate
14/14 ratings generated profit
Average Return
+158.49%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +158.49% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
I5X Analyst Recommendation Trends
Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
3
4
5
4
3
Buy
1
1
1
2
2
Hold
7
13
16
14
7
Sell
2
2
0
0
0
Strong Sell
0
0
0
0
0
total
13
20
22
20
12
Each month's total comprises the sum of three months' worth of ratings.
I5X Financial Forecast
I5X Stock Forecast FAQ
What is DE:I5X’s average 12-month price target, according to analysts?
Based on analyst ratings, Precigen, Inc.’s 12-month average price target is 7.14.
What is DE:I5X’s upside potential, based on the analysts’ average price target?
Precigen, Inc. has 125.18% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Precigen, Inc. a Buy, Sell or Hold?
Precigen, Inc. has a consensus rating of Strong Buy, which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
What is Precigen, Inc.’s share price target?
The average share price target for Precigen, Inc. is 7.14. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €7.35 ,and the lowest forecast is €6.92. The average share price target represents 125.18% Increase from the current price of €3.17.
The highest analyst share price target is €7.35 ,and the lowest forecast is €6.92. The average share price target represents 125.18% Increase from the current price of €3.17.
What do analysts say about Precigen, Inc.?
Precigen, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of Precigen, Inc.?
To buy shares of DE:I5X, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.